Provided by Tiger Trade Technology Pte. Ltd.

Summit Therapeutics PLC

16.91
+0.52003.17%
Post-market: 16.920.0100+0.06%19:58 EDT
Volume:13.06M
Turnover:224.22M
Market Cap:13.49B
PE:-15.13
High:17.72
Open:16.59
Low:16.17
Close:16.39
52wk High:29.23
52wk Low:12.07
Shares:797.75M
Float Shares:152.34M
Volume Ratio:1.41
T/O Rate:8.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1177
EPS(LYR):-1.4439
ROE:-192.50%
ROA:-101.61%
PB:21.41
PE(LYR):-11.71

Loading ...

Summit Therapeutics Shares Rise 4.1% Premarket After Co's Lung Cancer Drug With China-Based Partner Shows 15% Higher Survival Rate Than Rival's

THOMSON REUTERS
·
Jun 01

Summit Therapeutics Says Ivonescimab Improves Survival Over Tislelizumab in Phase III Lung Cancer Trial

MT Newswires Live
·
Jun 01

Stock Track | Summit Therapeutics Soars 9.06% in Pre-market on Positive Lung Cancer Drug Trial Results

Stock Track
·
Jun 01

Stock Track | Summit Therapeutics Soars 11.46% on Positive Ivonescimab Lung Cancer Trial Results

Stock Track
·
Jun 01

Summit Therapeutics posts HARMONi-6 ASCO 2026 plenary slides on ivonescimab in squamous NSCLC

Reuters
·
Jun 01

Summit Therapeutics announces OS results from Phase 3 HARMONi-6 trial

TIPRANKS
·
May 31

Summit Therapeutics presents new results from AK112-206 trial

TIPRANKS
·
May 31

CORRECTED-Akeso lung cancer drug helps patients live 15% longer than immunotherapy in China trial (May 31)

Reuters
·
May 31

BioNTech's Cancer Pipeline Seen Strengthening Ahead of Key Trial Results, UBS Says

MT Newswires Live
·
May 28

Assessing Summit Therapeutics (SMMT) Valuation As Ivonescimab Development Draws Fresh Investor Attention

Simply Wall St.
·
May 24

Summit Therapeutics Downgraded by H.C. Wainwright Amid Merck ADC Data Concerns

Deep News
·
May 23

This Summit Therapeutics Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Friday

Benzinga
·
May 23

S&P 500 Futures Climb In Premarket Trading; WR Berkley, Summit Therapeutics Lag

Dow Jones
·
May 22

Summit Therapeutics Plc : H.c. Wainwright Cuts to Neutral From Buy

THOMSON REUTERS
·
May 22

U.S. RESEARCH ROUNDUP-Jazz Pharmaceuticals, Target, Workday

Reuters
·
May 22

Used EV sales soar as drivers look to curb fuel costs

cityam
·
May 12

Summit Therapeutics (SMMT) Is Down 20.1% After Q1 2026 Net Loss Widens Sharply

Simply Wall St.
·
May 11

Stock Track | Summit Therapeutics Plummets 5.01% Intraday as H.C. Wainwright Cuts Target Price Amid Clinical Data Concerns

Stock Track
·
May 08

Stock Track | Summit Therapeutics Soars 5.42% Intraday on Citi Buy Rating and ASCO Catalyst Expectations

Stock Track
·
May 04

Roblox, Spotify, And Robinhood Are Among Top 10 Large-Cap Losers Last Week (April 27-May 1): Are The Others In Your Portfolio?

Benzinga_recent_news
·
May 03